CYS-26680-60913
3 vaccinations
3 coded responses
32 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 200 / DC
- Registered
- 2022-06-30
- Relationship
- Child or adolescent in my care
- Guardian
- FRS-12642-90648
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-29
Dose 1 — Moderna
-
2022-06-30
Registered in v-safe
-
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Redness · NoneUnder 3 check-in
-
2022-07-01
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Redness · NoneUnder 3 check-in
-
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Redness · NoneUnder 3 check-in
- 2022-07-04
- 2022-07-05
- 2022-07-08
- 2022-07-13
- 2022-07-20
-
2022-07-28
Dose 2 — Moderna
-
2022-07-28
Health check-in — day 0, dose 2, under 3Feeling: Fair · Fever · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-07-29
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Poor · Fever · Irritability/crying, Loss of appetiteUnder 3 check-in
- 2022-07-30
- 2022-07-31
- 2022-08-01
- 2022-08-02
- 2022-08-03
- 2022-08-04
- 2022-08-11
- 2022-08-18
- 2022-08-25
- 2022-09-01
- 2022-09-08
-
2022-10-27
Survey response — 3 months, dose 2, under 3MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: A series of upper respiratory infections thanks to being on preschool for the first timeMedDRA releases: 2024-11 · check-in free text available
-
2022-10-27
Report sent to call center — 3 months, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-28
-
2022-11-01
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-16
Dose 3 — Moderna
-
2022-12-18
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Site: Pain, Redness, Swelling/hardness · NoneUnder 3 check-in
-
2022-12-19
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Site: Pain, Redness, Swelling/hardness · NoneUnder 3 check-in
-
2022-12-21
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Site: Redness · NoneUnder 3 check-in
- 2022-12-23
- 2023-01-01
- 2023-01-09
- 2023-01-13
-
2023-01-20
Survey response — day 35, dose 3, under 3MedDRA: Exposure to SARS-CoV-2, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-01-27
-
2023-03-19
Survey response — 3 months, dose 3, under 3MedDRA: Viral infection — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-19
Report sent to call center — 3 months, dose 3, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-29 | Moderna | No |
| 2 | 2022-07-28 | Moderna | No |
| 3 | 2022-12-16 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: A series of upper respiratory infections thanks to being on preschool for the first time
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release